Long-term efficacy and safety outcomes with OROS-MPH in adults with ADHD
Long-term efficacy and safety outcomes with OROS-MPH in adults with ADHD
About this item
Full title
Author / Creator
Publisher
Cambridge, UK: Cambridge University Press
Journal title
Language
English
Formats
Publication information
Publisher
Cambridge, UK: Cambridge University Press
Subjects
More information
Scope and Contents
Contents
Methylphenidate (MPH) is widely prescribed for adults with attention deficit hyperactivity disorder (ADHD), but data on long-term treatment and maintenance of effect are lacking. Osmotic release oral system-methylphenidate (OROS–MPH) was evaluated in a 52-wk open-label study in subjects who had previously completed a short-term placebo-controlled t...
Alternative Titles
Full title
Long-term efficacy and safety outcomes with OROS-MPH in adults with ADHD
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3243903
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3243903
Other Identifiers
ISSN
1461-1457
E-ISSN
1469-5111
DOI
10.1017/S1461145711001131
